TherapeuticsMD (TXMD) Return on Assets: 2011-2025
Historic Return on Assets for TherapeuticsMD (TXMD) over the last 9 years, with Sep 2025 value amounting to 0.01%.
- TherapeuticsMD's Return on Assets fell 1.00% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of 0.00% for FY2024, which is 4.00% up from last year.
- According to the latest figures from Q3 2025, TherapeuticsMD's Return on Assets is 0.01%, which was up 167.89% from 0.00% recorded in Q2 2025.
- TherapeuticsMD's 5-year Return on Assets high stood at 1.88% for Q1 2023, and its period low was -0.82% during Q3 2021.
- Moreover, its 3-year median value for Return on Assets was 0.00% (2024), whereas its average is 0.21%.
- As far as peak fluctuations go, TherapeuticsMD's Return on Assets surged by 235bps in 2023, and later crashed by 196bps in 2024.
- TherapeuticsMD's Return on Assets (Quarterly) stood at -0.42% in 2021, then soared by 141bps to 0.99% in 2022, then crashed by 110bps to -0.11% in 2023, then climbed by 11bps to 0.00% in 2024, then declined by 1bps to 0.01% in 2025.
- Its Return on Assets was 0.01% in Q3 2025, compared to 0.00% in Q2 2025 and 0.00% in Q1 2025.